Immunome, Inc. (IMNM) Stock Analysis

Free AI-powered analysis and research for Immunome, Inc. stock

Sector: Healthcare

Analyze Immunome, Inc. (IMNM) Stock

Immunome, Inc. (IMNM) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into IMNM stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Immunome, Inc. stock.

Analyze IMNM Now →

📰 Latest Update

Immunome, Inc. (IMNM) Reports Submission of an NDA for Varegacestat in Desmoid Tumors

Tue, May 12, 2026 at 12:01 AM UTC 3 min read

Immunome, Inc. (IMNM) has submitted a New Drug Application (NDA) for Varegacestat, targeting desmoid tumors. This submission is significant as it represents a critical step in bringing a potential treatment to market, which could enhance the company's growth prospects and attract investor interest. Successful approval could lead to increased revenue streams and bolster Immunome's position in the oncology sector.

Read full article →